Neurolign Introduces NeurolignFit™ to Bring 30+ Years of Clinical Research in Brain Health to Consumer Wellness

Neurolign™, a leader in clinical eye tracking and neuro-functional diagnostic testing, announced today the launch of…

FAIR Health to Launch Initiative Promoting Health Insurance Literacy to Hispanic and Latinx Communities

With a generous grant from The New York Community Trust (The Trust), FAIR Health, a national,…

National Cancer Research Institute endorses CBD Science Group as they pioneer Real World research into Cancer pain

CBD Science Group (the ‘Company‘) is delighted to announce a highly sought-after endorsement from the National…

Neurocrine Biosciences to Present at Upcoming Healthcare Conferences

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that members of the management team will participate at the…

Fusion Pharmaceuticals to Participate in Upcoming Investor Conferences

 Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines,…

Eliminating Toxic Chemicals is Critical in Preventing Childhood Cancer – New Data Shows Incidence Rates Continue to Rise

With the number of children diagnosed with cancer growing significantly since 1975, Barry A. Cik, Board-Certified Environmental…

Veepoo technology releases the health smartwatch

 VEEPOO WATCH RIG, equipped with multiple health monitoring functions featuring its EKG/ECG monitoring service, can effectively detect…

Doximity to Participate in a Virtual Fireside Chat at Morgan Stanley’s 19th Annual Global Healthcare Conference

 Doximity, Inc. (NYSE: DOCS) today announced that Anna Bryson, CFO, will participate in a virtual fireside chat at…

Global Animal Health Monitoring Software Market Report 2021 Featuring Carestream Health, Clientrax, Ezyvet, Finnish Net Solutions, Firmcloud, Henry Schein

– The “Global Animal Health Monitoring Software Market (2021-2026) by Deployment, End User, Animals and Geography, IGR…

Antengene Announces Approval of the Phase II Study of Selinexor for the Treatment of Myelofibrosis in China

Antengene Corporation Limited (“Antengene”, SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and…